DETECTION AND RAPID CHARACTERIZATION OF COVID19 AND THE PATIENT

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:1 publications

Grant number: COV20_00279

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Principal Investigator

    FELIPE J CHAVES MARTÍNEZ
  • Research Location

    Spain
  • Lead Research Institution

    FUNDACION PARA LA INVESTIGACION DE HOSPITAL CLINICO DE LA COMUNIDAD VALENCIANA
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The life cycle of coronaviruses allows differentiation between the encapsulated virus and its infection and replication processes. We will develop modular kits that allow, on the one hand, to determine the presence of the virus, the presence of viral processes involved in the infection and the determination of those variables that may be relevant in the development of the disease (viral and human). The kits will be based on isothermal amplification and rapid PCR of the regions of interest and their rapid detection (15-30 minutes the presence of the virus, available in 1 - 2 months). In a second kit-module, from these amplified and those of interest in relation to the patient, libraries will be generated to be sequenced using Nanopore systems. This second part of the study will make it possible to know the strain of the virus and the variables of the patient that are relevant in the disease, making a report based on the available data and including other clinical variables of interest.

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Sample Treatment with Trypsin for RT-LAMP COVID-19 Diagnosis.